Multiple sclerosis onset disease

Common Questions and Answers about Multiple sclerosis onset disease

multiple-sclerosis

382218 tn?1341181487 Factors predisposing to benign multiple sclerosis included younger age at onset, shorter disease duration and a lower number of relapses. We conclude that a substantial proportion of patients with multiple sclerosis from Crete follow a rather benign disease course, and this may relate to the genetic background of the population and/or to environmental factors.
333672 tn?1273792789 We seem to have this discussion interminably and yet the types of MS still seem elusive. Just to satisfy my own curiosity, I got my hands on a copy of the article on which the current four clinical types are based: Defining the clinical course of multiple sclerosis: results of an international survey by Fred D. Lublin and Stephen C. Reingold for the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. In Neurology.
Avatar m tn There is no known connection, but many of us suffer with extremely cold fingers and toes as part of our MS, but don't have the Raynaud's symptoms of white, waxy digits. And as Bob points out many people have more than one disease gong on.
Avatar f tn Approximately 50% of patients with RRMS convert to Secondary Progressive Multiple Sclerosis (SPMS) within 10 years of disease onset. After 30 years, this figure rises to 90%. At any one time, the Relapsing-Remitting form of the disease accounts around 55% of all people with multiple sclerosis. SPMS is characterised by a steady progression of clinical neurological damage with or without superimposed relapses and minor remissions and plateaux.
Avatar f tn org/brochures and you can get many publications from The Basic Facts, The History of Multiple Sclerosis, to publications on Newly Diagnosed, Employment issues, Staying Well, Managing Specific Issues, Managing Major changes, And the list goes on and on.
Avatar m tn i had been diagonised with multiple sclerosis in the year 2001. now i am not able to walk. i am also not able to see clearly. my speech is also not clear. i think my type of ms is primary progressive since my condition has worsened gradually. pl suggest some medicines or other alternative therapy.
Avatar n tn Everything seemed minor until the last line, which raised the possibility of demyelinating process, including but not limited to entities such as multiple sclerosis. Please follow-up with your neurologist for further workup and/or evaluation.
Avatar m tn my sister (24) was diagnosed Multiple Sclerosis in 2010, responded to steroid. now she suffered sudden & complete loss of vision in her left eye. she has been put on SOLUMEDROL. please suggest any available treatment modalities world over ? chances of return of vision ??
Avatar f tn clinical characteristics, prognostic factors and differential diagnosis. Neurol Sci. 2004 Nov;25 Suppl 4:S350-5.
Avatar n tn My DR has diagnosed me with Non Progressive Relapsing Multiple Sclerosis. I am getting ready to do the 2nd inusion of Rituximab. I cannot find any information about this specific diagnosis. I asked him the question and he told me that this 'miracle' drug will not let the disease progress. Does anyone have any information at all on this type of diagnosis?
Avatar n tn Hello. There have been debates about childhood onset multiple sclerosis. The lesions in your son's brain MRI hint towards a slow and probably progressive disease. I guess he has headache as the only symptoms. A lot of researchers have studied childhood onset multiple sclerosis. As young as 5 year olds have been diagnosed to have MS. The MRI report described here suggests a possible demyelination. The diagnostic criteria used for adults can be used for children also.
382218 tn?1341181487 The discovery of neuromyelitis optica (NMO)-immunoglobulin (Ig)G and its target antigen aquaporin 4 (AQP4) redefined NMO, historically considered a multiple sclerosis (MS) variant, as a specific disease entity. NMO and MS have divergent responses to immunotherapy and it is important to distinguish the conditions at disease onset.
572651 tn?1530999357 There was exciting news coming from New Orleans last week at the American Academy of Neurology conference. Here is a brief synopsis of the highlights, taken from an email I received today. Even the ones that aren't MS related make for some good reading. you can find links to all of these stories through their website at http://www.medpagetoday.
Avatar m tn Using the EAE mouse model for multiple sclerosis (MS), the inventors have shown that the disease course and severity can be ameliorated with daily administration of antihistamine. This approach has the potential for treating MS with less side-effects and more convenient dosing than current therapeutic interventions. Stage of Research EAE mice treated daily with anti-histamine receptor 1 have decreased disease severity and delayed onset of the disease compared to controls.